AVOTEO

AVOTEO

ICO Ended
7,031 Views
AVOTEO makes crowdfunding and investing both rewarding and fun.

The team builds a crowdfunding platform with an integrated talent pool. Holders of the AVO token will have the right to vote on the projects they want to be funded. The most voted projects are then selected on a regular basis and get funding from a funding wallet, which is filled by a 10% transaction tax (4% funding pool, 3% redistribution, 3% liquidity). Financed projects assign company shares to AVOTEO in return and AVO holders will participate in the success of the projects.

Crowdfunding platform
Present your projects and apply for funding or vote for projects and participate in their success. All you have to do as an investor is to vote for projects you think are promising. Additional financial contribution is not necessary, as the winning projects are funded from the funding wallet.

Talent pool
Find potential team members as a project owner or offer your services and find projects you can participate in as a professional.

Voting
Not only can AVO holders vote on projects they want to be funded. They also have a say in the future development of AVOTEO itself.

Community
Interaction, a platform that is fun to use and a supportive environment for projects are further core elements of AVOTEO.
8.6
TOTAL SCORE
8.5
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
ICO Time: 31 Oct 2021 - 15 Aug 2022
Country: Spain
Token info
Ticker: AVO
Platform: Binance Chain
Token Type: BEP-20
Available for sale: 500,000,000 AVO (50%)
Total supply: 1,000,000,000 AVO
Financial
ICO Price: 0,05 USD = 1 AVO
Accepting: BNB, BTC, ETH, USDT
Soft cap: 100,000 USD
Hard cap: 24,600,000 USD
Bonuses: Up to 40%
September 2021
Website release , finalizing whitepaper.<br />
October 2021
Private sell, kick off social media accounts, start marketing campaign.<br />
December 2021
Presale phase 1, start working on AVOTEO platform, team doxing.<br />
Q1 2022
Beginning presale phase 2.<br />
Q2 2022
DEX listing, beta version release of the AVOTEO platform, onboarding of private sale/crowdsale investors.<br />
Q3 2022
AVOTEO platform open for public
Q4 2022
Funding first AVOTEO projects, massive marketing campaign, CEX listing.
Fagan Kourbanov
Founder, CEO
Participates in a number of projects
Eugen Timoschin
Chief Operating Officer
Participates in a number of projects
Ufuk Karatag
Head of Marketing
Participates in a number of projects
Mehdi Mallah
International Business Development
Participates in a number of projects
Dmitri Pichkurov
Head of IT
Participates in a number of projects
Arwin Ralf
Head of Strategic Development
Participates in a number of projects

Advisors (3)

Faisal El Kasmi
Financial Advisor
Participates in a number of projects
Luca Greco
Investor, Crypto Advisor
Participates in a number of projects
Luca Morandi
Investor, Social Media Advisor
Participates in a number of projects
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
BitMinutes
BitMinutes is the first prepaid airtime token to provide low-cost financial services to the world's two billion unbanked consumers. BitMinutes serve as the universal cryptocurrency for enabling global telecommunications providers, retail merchants and a network of trusted agents to offer free money transfer and guaranteed loans to six billion cellphone users. The primary goal of Bitminutes ICO is to provide access to key financial services for over two billion unbanked worldwide.
Upcoming
Xsure
Xsure is a decentralized risk management platform that facilitates real-time communication between insurance providers and the end customer. With the help of machine learning and blockchain trust-less governance technologies we have managed to eliminate third parties from the whole insurance life-cycle and turn it into a dynamic process instead of a static one.
Upcoming
Dailycoin
DailyCoin has built a decentralized eCommerce platform, on the Ethereum Blockchain, and payment solution system. The aim is to provide that financial payment solution with little or no hassle, with next to nothing or no transaction fee, allowing people to buy or pay for those services they are used to on their platforms or merchant sites. The goal is to make everyone’s daily experience an easy one while buying those tickets, paying for shopping items or even making hotel reservations.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.
Upcoming
Beyond Seen Screen
Beyond Seen Screen has created a platform that enables interactivity with video content. With Beyond Seen Screen watching video content is no longer a passive action, a one-way street. The platform enables content producers and content distribution companies to link additional information to the video content. Viewers will no longer only passively receive adverts, trailers and other video content but will have ability to interactively engage with them by using their mobile device.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.